Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-06-20

Clinical Trial Update: UK ANDROMEDA-Shock-2 RCT [NA]

View source ↗

Summary

The UK ANDROMEDA-Shock-2 randomized controlled trial investigating septic shock is currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Guy's and St Thomas' NHS Foundation Trust | Conditions: Septic Shock | NA | Status: NOT_YET_RECRUITING